About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Stroke and Anxiety Reduction | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT06013982

Stroke and Anxiety Reduction

The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medi...

Lead sponsor: NYU Langone Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

NYU Langone Health

Age

18 - 89 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Be diagnosed with an acute stroke
•Able to speak, read and write in English
•Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
•Discharged to home
•Internet access including email
•Willingness to participate in an anxiety reduction program
•Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
•Must be medically stable

Exclusion Criteria

•Not diagnosed with an acute stroke
•Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
•Not discharged to home
•No internet access including email
•Unwilling or unable to participate in an anxiety reduction program
•Cognitively impaired
•Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
•Not medically stable

Related studies

RECRUITINGPhase 1

Phase I Split-Belt Treadmill Dosing for Subacute Stroke

NCT07469163 · Subacute Stroke, Stroke, and more

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

NCT07236216 · Hemorrhagic Stroke, Ischemic Stroke, and more

SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke

NCT03737786 · Acute Stroke

Using AI Systems to Optimize the Clinical Outcome of Stroke Patients

NCT06828679 · Acute Stroke Intervention, Acute Stroke, and more

Mirror Therapy for Hand Function Recovery in Acute Stroke

NCT07204067 · Acute Stroke

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 18, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment34

Start dateAug 2023

Last updatedApr 18, 2025

Condition

Locations shown

NYU Langone Health

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions